EGFR and lung adenocarcinoma: Thirty-nine EGFR ex20ins patients with stage IV lung adenocarcinoma started chemotherapy as first-line treatment, 15 patients received EGFR-TKI therapy as first-line therapy, and immunotherapy was administered as a first-line setting in 10 patients.